NCT02106858View on ClinicalTrials.gov

Stivarga Regulatory Post-Marketing Surveillance Study in Korea

CompletedOBSERVATIONAL

Enrollment

316

Participants

Timeline

Start Date

June 25, 2014

Primary Completion Date

May 7, 2019

Study Completion Date

May 7, 2019

Conditions

Colorectal Neoplasms

Interventions

DRUG

Regorafenib (Stivarga,BAY73-4506)

Patients treated by Physician with Stivarga under approved local prescriptions

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY